within Pharmacolibrary.Drugs.D_Dermatologicals.D08A_AntisepticsAndDisinfectants.D08AX08_Ethanol;

model Ethanol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 1.75e-05,
    adminDuration = 600,
    adminMass = 40000 / 1000000,
    adminCount = 1,
    Vd = 0.0006,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.003,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ethanol</td></tr><tr><td>ATC code:</td><td>D08AX08</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>40000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.6</td><td>L</td></tr>
    <tr><td>clearance:</td><td>15</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ethanol, also known as ethyl alcohol, is a volatile, flammable, colorless liquid commonly used as an antiseptic and disinfectant for topical application, and is the principal psychoactive ingredient in alcoholic beverages. It is not currently used as an approved therapeutic drug but is still in use for certain medical applications, such as antidote therapy in methanol or ethylene glycol poisoning, and for its antimicrobial properties in skin disinfectants.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers; parameters estimated for intravenous and oral route in typical populations, based on published literature.</p><h4>References</h4><ol><li><p>Büsker, S, et al., &amp; Fuhr, U (2023). Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States. <i>Journal of clinical pharmacology</i> 63(6) 681–694. DOI:<a href=\"https://doi.org/10.1002/jcph.2205\">10.1002/jcph.2205</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36688276/\">https://pubmed.ncbi.nlm.nih.gov/36688276</a></p></li><li><p>Knych, HK, et al., &amp; McKemie, DS (2024). Pharmacokinetics of Ethyl Glucuronide and Ethyl Sulfate and Pharmacodynamic Effects Following Intravenous and Oral Administration of Ethanol to Exercised Horses. <i>Drug testing and analysis</i> None –. DOI:<a href=\"https://doi.org/10.1002/dta.3803\">10.1002/dta.3803</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39279026/\">https://pubmed.ncbi.nlm.nih.gov/39279026</a></p></li><li><p>Imbert, B, et al., &amp; Simon, N (2016). Population Pharmacokinetics of High-Dose Oxazepam in Alcohol-Dependent Patients: Is There a Risk of Accumulation?. <i>Therapeutic drug monitoring</i> 38(2) 253–258. DOI:<a href=\"https://doi.org/10.1097/FTD.0000000000000262\">10.1097/FTD.0000000000000262</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26580099/\">https://pubmed.ncbi.nlm.nih.gov/26580099</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.D.D08AX08 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ethanol;
